Chunyang Mu Junyi Shen Xinrui Zhu Wei Peng Xiaoyun Zhang Tianfu Wen
10.3389/fonc.2023.1096955
Front Oncol
2023 May 16;13:1096955.
combination therapy lenvatinib programmed death-1 antibody recurrent hepatocellular carcinoma trans-arterial chemoembolization
CC BY
https://pubmed.ncbi.nlm.nih.gov/37260972/
PMC10228745
37260972
The efficacy and safety of lenvatinib plus transarterial chemoembolization in combination with PD-1 antibody in treatment of unresectable recurrent hepatocellular carcinoma: a case series report
2023